Literature DB >> 11331772

Phenotypic consequences of lung-specific inducible expression of FGF-3.

B Zhao1, S S Chua, M M Burcin, S D Reynolds, B R Stripp, R A Edwards, M J Finegold, S Y Tsai, F J DeMayo.   

Abstract

Members of the fibroblast growth factor (FGF) family play a critical role in embryonic lung development and adult lung physiology. The in vivo investigation of the role FGFs play in the adult lung has been hampered because the constitutive pulmonary expression of these factors often has deleterious effects and frequently results in neonatal lethality. To circumvent these shortcomings, we expressed FGF-3 in the lungs under the control of the progesterone antagonist-responsive binary transgenic system. Four binary transgenic lines were obtained that showed ligand-dependent induction of FGF-3 with induced levels of FGF-3 expression dependent on the levels of expression of the GLp65 regulator as well as the dose of the progesterone antagonist, RU486, administered. FGF-3 expression in the adult mouse lung resulted in two phenotypes depending on the levels of induction of FGF-3. Low levels of FGF-3 expression resulted in massive free alveolar macrophage infiltration. High levels of FGF-3 expression resulted in diffuse alveolar type II cell hyperplasia. Both phenotypes were reversible after the withdrawal of RU486. This system will be a valuable means of investigating the diverse roles of FGFs in the adult lung.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331772      PMCID: PMC33310          DOI: 10.1073/pnas.101116598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.

Authors:  S D Finkelstein; T Hasegawa; T Colby; S A Yousem
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Hormone-like effects of fibroblast growth factors (FGFs) in the nervous system.

Authors:  P Cuevas
Journal:  Surg Neurol       Date:  1998-12

3.  Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus.

Authors:  A M Gonzalez; D J Hill; A Logan; P A Maher; A Baird
Journal:  Pediatr Res       Date:  1996-03       Impact factor: 3.756

4.  Ligand-inducible and liver-specific target gene expression in transgenic mice.

Authors:  Y Wang; F J DeMayo; S Y Tsai; B W O'Malley
Journal:  Nat Biotechnol       Date:  1997-03       Impact factor: 54.908

5.  Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway.

Authors:  L F Weikert; J P Lopez; R Abdolrasulnia; Z C Chroneos; V L Shepherd
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-08       Impact factor: 5.464

6.  GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice.

Authors:  J A Huffman Reed; W R Rice; Z K Zsengellér; S E Wert; G Dranoff; J A Whitsett
Journal:  Am J Physiol       Date:  1997-10

7.  MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.

Authors:  D Daphna-Iken; D B Shankar; A Lawshé; D M Ornitz; G M Shackleford; C A MacArthur
Journal:  Oncogene       Date:  1998-11-26       Impact factor: 9.867

8.  Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage.

Authors:  J R Wright; D C Youmans
Journal:  Am J Physiol       Date:  1993-04

9.  Fgf10 is essential for limb and lung formation.

Authors:  K Sekine; H Ohuchi; M Fujiwara; M Yamasaki; T Yoshizawa; T Sato; N Yagishita; D Matsui; Y Koga; N Itoh; S Kato
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

10.  The int-2 gene product acts as an epithelial growth factor in transgenic mice.

Authors:  W J Muller; F S Lee; C Dickson; G Peters; P Pattengale; P Leder
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  9 in total

1.  p63 is the molecular switch for initiation of an epithelial stratification program.

Authors:  Maranke I Koster; Soeun Kim; Alea A Mills; Francesco J DeMayo; Dennis R Roop
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

2.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Authors:  G H Fisher; S L Wellen; D Klimstra; J M Lenczowski; J W Tichelaar; M J Lizak; J A Whitsett; A Koretsky; H E Varmus
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.

Authors:  Ami Mankodi; Thurman M Wheeler; Reena Shetty; Kelly M Salceies; Mark W Becher; Charles A Thornton
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

4.  Inducible expression of FGF-3 in mouse mammary gland.

Authors:  Elly S W Ngan; Zhi-Qing Ma; Steven S Chua; Francesco J DeMayo; Sophia Y Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

5.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

6.  Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.

Authors:  Yongjun Yin; Tomoko Betsuyaku; Joel R Garbow; Jinbai Miao; Ramaswamy Govindan; David M Ornitz
Journal:  Cancer Res       Date:  2013-07-18       Impact factor: 12.701

7.  Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

Authors:  Jeremy H Tchaicha; Esra A Akbay; Abigail Altabef; Oliver R Mikse; Eiki Kikuchi; Kevin Rhee; Rachel G Liao; Roderick T Bronson; Lynette M Sholl; Matthew Meyerson; Peter S Hammerman; Kwok-Kin Wong
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

8.  Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.

Authors:  Jenifer L Marks; Michael D McLellan; Maureen F Zakowski; Alex E Lash; Yumi Kasai; Stephen Broderick; Inderpal S Sarkaria; Duykhanh Pham; Bhuvanesh Singh; Tracie L Miner; Ginger A Fewell; Lucinda L Fulton; Elaine R Mardis; Richard K Wilson; Mark G Kris; Valerie W Rusch; Harold Varmus; William Pao
Journal:  PLoS One       Date:  2007-05-09       Impact factor: 3.240

9.  Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress.

Authors:  Milad Rezvani; Juliane Wilde; Patricia Vitt; Beena Mailaparambil; Ruth Grychtol; Marcus Krueger; Andrea Heinzmann
Journal:  Dis Markers       Date:  2013-10-31       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.